Healthcare Services

Insomnia Market Insights Exploring Expansion Opportunities Through 2030

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Insomnia Market During 2026–2030?

The insomnia market has demonstrated strong growth in recent years. It is anticipated to expand from $5.22 billion in 2025 to $5.52 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. This historic growth is attributable to an increasing prevalence of sleep disorders, heightened stress and evolving lifestyle patterns, the widespread application of benzodiazepines and sedatives, rising insomnia diagnosis rates, and the expansion of sleep clinics and specialists.

The market for insomnia treatments is projected to experience robust expansion over the coming years. This market is set to reach a valuation of $7.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This anticipated growth stems from several factors, including the increased embrace of digital therapeutics, a rising demand for safer and long-term insomnia solutions, the expanding geriatric population, heightened awareness of mental health issues, and wider availability of online and retail pharmacy services. Significant trends expected during this period involve a greater uptake of non-pharmacological insomnia treatments, an increase in the application of cognitive behavioral therapy for insomnia, a developing preference for individualized sleep management, the broader implementation of combination therapy methods, and an enhanced recognition of chronic insomnia as a serious medical condition.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp

Which Growth Drivers Are Expected To Support The Insomnia Market Forward?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the insomnia market in the future. A chronic disease is defined as an ailment persisting for at least three months, with the potential to worsen over time. Individuals afflicted by long-term health problems like cardiovascular disorders, diabetes, and chronic pain conditions frequently encounter insomnia or other sleep disturbances as a co-occurring condition. This growing incidence generates a need for effective treatments and management approaches for insomnia, thereby stimulating the market for offerings aimed at sleep disorders. For example, data from April 2025 by the Centers for Disease Control and Prevention, a US-based federal public health agency, indicated that in 2023, 76.4% of US adults, approximately 194 million individuals, reported suffering from at least one chronic condition. The prevalence was observed to be 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increasing prevalence of chronic diseases is a key factor propelling the growth of the insomnia market.

How Is The Insomnia Market Examined Through Segment Analysis?

The insomnia market covered in this report is segmented –

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements

Which Trends Are Expected To Shape The Insomnia Market?

Major companies operating in the insomnia market are actively developing novel products, such as zaleplon-based insomnia drugs, to secure a competitive advantage. Zaleplon is a non-benzodiazepine sedative-hypnotic medication specifically used for the short-term management of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical company, introduced Zaledeep Cap., making it the first insomnia treatment in South Korea to utilize zaleplon as its primary ingredient. Zaleplon, a non-benzodiazepine drug with FDA approval for treating insomnia, is notable for its rapid onset of action, short half-life, and minimal interference with daily activities. With the rising incidence of insomnia in modern society, the launch of Zaledeep Cap. is expected to offer a new and effective therapeutic option, aiming to improve sleep quality and overall well-being for individuals suffering from insomnia.

Which Organizations Are Involved In The Insomnia Market?

Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Access The Complete Insomnia Market Report:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Which Region Accounts For The Highest Share Of The Insomnia Market?

North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Insomnia Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12120&type=smp

Browse Through More Reports Similar to the Global Insomnia Market 2026, By The Business Research Company

Hospitals And Outpatient Care Centers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospitals-and-outpatient-care-centers-global-market-report

Healthcare Services Market 2026

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Hospitals And Outpatient Care Centers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospitals-and-outpatient-care-centers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795